Zhang, Z.; Yu, G.; Eresen, A.; Hou, Q.; Webster, S.; Amirrad, F.; Nauli, S.; Zhang, Z.
Therapy Combining Sorafenib and Natural Killer Cells for Hepatocellular Carcinoma: Insights from Magnetic Resonance Imaging and Histological Analyses. Cancers 2025, 17, 699.
https://doi.org/10.3390/cancers17040699
AMA Style
Zhang Z, Yu G, Eresen A, Hou Q, Webster S, Amirrad F, Nauli S, Zhang Z.
Therapy Combining Sorafenib and Natural Killer Cells for Hepatocellular Carcinoma: Insights from Magnetic Resonance Imaging and Histological Analyses. Cancers. 2025; 17(4):699.
https://doi.org/10.3390/cancers17040699
Chicago/Turabian Style
Zhang, Zigeng, Guangbo Yu, Aydin Eresen, Qiaoming Hou, Sha Webster, Farideh Amirrad, Surya Nauli, and Zhuoli Zhang.
2025. "Therapy Combining Sorafenib and Natural Killer Cells for Hepatocellular Carcinoma: Insights from Magnetic Resonance Imaging and Histological Analyses" Cancers 17, no. 4: 699.
https://doi.org/10.3390/cancers17040699
APA Style
Zhang, Z., Yu, G., Eresen, A., Hou, Q., Webster, S., Amirrad, F., Nauli, S., & Zhang, Z.
(2025). Therapy Combining Sorafenib and Natural Killer Cells for Hepatocellular Carcinoma: Insights from Magnetic Resonance Imaging and Histological Analyses. Cancers, 17(4), 699.
https://doi.org/10.3390/cancers17040699
